Canaccord Genuity Group reissued their buy rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research note published on Tuesday morning, Benzinga reports. Canaccord Genuity Group currently has a $11.00 price objective on the stock. Other equities research analysts have also recently issued research reports about the stock. Guggenheim upgraded shares of […]
Canaccord Genuity Group reiterated their buy rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research report released on Tuesday, Benzinga reports. Canaccord Genuity Group currently has a $11.00 target price on the stock. Other equities analysts also recently issued research reports about the company. Cantor Fitzgerald reissued an overweight rating and […]
Health Catalyst (NASDAQ:HCAT) Price Target Cut to $13 00 by Analysts at Wells Fargo & Company wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
Health Catalyst (NASDAQ:HCAT – Get Free Report)‘s stock had its “overweight” rating reaffirmed by Cantor Fitzgerald in a report issued on Wednesday, Benzinga reports. They currently have a $16.00 price objective on the stock. Cantor Fitzgerald’s price objective would indicate a potential upside of 156.41% from the stock’s previous close. Other research analysts have also […]
Cantor Fitzgerald reaffirmed their overweight rating on shares of Health Catalyst (NASDAQ:HCAT – Free Report) in a research report sent to investors on Tuesday, Benzinga reports. They currently have a $16.00 price target on the stock. A number of other equities analysts also recently commented on the stock. Barclays initiated coverage on shares of Health […]